ALNY

Trade Alnylam Pharmaceuticals, Inc. - ALNY stock price

1m
5m
15m
30m
1H
4H
1D
1W
History

ALNY

Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel therapeutics based on RNA interference (RNAi). Its pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, and hepatic infectious diseases. The company's clinical development programs include Patisiran, which is in Phase III clinical trial for the treatment of hereditary transthyretin-mediated amyloidosis; Givosiran that is in Phase III trial to treat acute hepatic porphyrias; Fitusiran, an investigational RNAi therapeutic that is in Phase II open-label extension and Phase III clinical trial for the treatment of hemophilia and rare bleeding disorders; and Inclisiran, which is in III clinical trial for hypercholesterolemia. Its clinical programs also include ALN-TTRsc02, an investigational RNAi therapeutic targeting TTR, which is in the Phase I clinical trial for the treatment of various forms of ATTR amyloidosis; Lumasiran (ALN-GO1) that is in Phase I/II clinical trial for the treatment of primary hyperoxaluria type 1; and Cemdisiran (ALN-CC5), which is in the Phase II clinical trial for the treatment of complement-mediated diseases. The company has strategic alliances primarily with Sanofi Genzyme; The Medicines Company; Monsanto Company; Takeda Pharmaceutical Company Limited; Ionis Pharmaceuticals, Inc; and Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. was founded in 2002 and is headquartered in Cambridge, Massachusetts.
White Paper Declaration
iPhone Image
Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat
iMac Image
Trade the world’s top tokenised stocks, indices, commodities and currencies with the help of crypto or fiat
iMac Image
1BTC
Invest
20BTC
Profit
Leverage:
x20
The Power Of Leverage
Trade in the big leagues with 100 Bitcoin for every 1 Bitcoin you put in

ALNY price history

Date Close Change Change(%) Open High Low
Jun 29, 2022 145.09 3.96 2.81% 141.13 145.81 139.83
Jun 28, 2022 142.02 -4.22 -2.89% 146.24 146.45 139.19
Jun 27, 2022 146.23 3.18 2.22% 143.05 146.29 141.15
Jun 24, 2022 147.33 0.00 0.00% 147.33 147.86 144.01
Jun 23, 2022 146.22 4.80 3.39% 141.42 146.23 137.52
Jun 22, 2022 141.32 4.47 3.27% 136.85 142.40 134.93
Jun 21, 2022 138.84 1.92 1.40% 136.92 140.87 136.92
Jun 17, 2022 136.92 3.16 2.36% 133.76 138.88 133.76
Jun 16, 2022 134.59 4.37 3.36% 130.22 134.85 128.28
Jun 15, 2022 135.21 2.16 1.62% 133.05 136.88 132.68
Jun 14, 2022 133.35 4.99 3.89% 128.36 136.68 128.36
Jun 13, 2022 127.30 0.35 0.28% 126.95 128.30 122.30
Jun 10, 2022 131.96 -0.19 -0.14% 132.15 133.74 131.05
Jun 9, 2022 134.83 -3.35 -2.42% 138.18 138.80 134.37
Jun 8, 2022 139.23 7.25 5.49% 131.98 141.16 131.98
Jun 7, 2022 133.83 4.50 3.48% 129.33 134.06 129.33
Jun 6, 2022 131.54 -0.56 -0.42% 132.10 132.48 130.03
Jun 3, 2022 131.24 7.47 6.04% 123.77 131.58 123.77
Jun 2, 2022 125.16 3.31 2.72% 121.85 125.40 119.94
Jun 1, 2022 122.88 -1.39 -1.12% 124.27 128.64 122.72